Eastern Cooperative Oncology Group Chair's Office

东部肿瘤合作组主席办公室

基本信息

批准号：
7262496
负责人：
ROBERT L COMIS
金额：
$ 64.45万
依托单位：
DREXEL UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
1999
资助国家：
美国
起止时间：
1999-09-22 至 2010-04-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7262496
关键词：
ABT-627 Access to Information Acetates Achievement Activity Cycles Acute Acute Myelocytic Leukemia Addendum Address Adjuvant Administrator Adopted Adult Adverse event Advertising Advisory Committees Advocacy Advocate African American Age Age-Years Agreement Air Amendment Angiogenesis Inhibitors Antineoplastic Agents Apoptosis Appearance Appendix Applications Grants Appointment Area Atrasentan Attention Authorization documentation Autologous Autologous Bone Marrow Transplantation Award Awareness Benefits and Risks Biological Products Biology Birds Blinded Bone Marrow Boston Breast Budgets Businesses CD34 gene CSF3 gene Cancer Biology Cancer Center Cancer Patient Cancer Trials Support Unit Cancer and Leukemia Group B Cancer cell line Carcinoma Caring Cell Line Cells Certificate of Confidentiality Certification Characteristics Charge Chemoprevention Children&apos s Oncology Group Chromosome abnormality Chronic Classification Clinic Clinical Clinical Cancer Center Clinical Oncology Clinical Practice Guideline Clinical Research Clinical Trials Clinical Trials Cooperative Group Clinical Trials Data Monitoring Committees Clinical Trials Design Closure Code Collaborations Colorectal Cancer Commit Communication Communication Programs Communities Community Clinical Oncology Program Community Networks Community Physician Complex Computer Security Conceptions Condition Conduct Clinical Trials Confidentiality Confidentiality of Patient Information Conflict (Psychology)Conflict of Interest Conscious Consent Consent Forms Constitution Contracts Controlled Study Cooperative Research and Development Agreement Correlative Study Counseling Country Cues Cyclosporins Cytarabine Daily Dalteparin Data Data Reporting Data Sources Data Storage and Retrieval Databases Decision Making Delaware Denileukin Diftitox Development Developmental Therapeutics Program Dexamethasone Dexamethasone/Doxorubicin/PSC 833/Vincristine Diagnosis Diagnostic Neoplasm Staging Diarrhea Disclosure Disease Disease remission Disseminated Malignant Neoplasm Docetaxel/Doxorubicin Docetaxel/Estramustine Docetaxel/Irinotecan Doctor of Medicine Doctor of Pharmacy Doctor of Philosophy Documentation Dose Double-Blind Method Drug Approval Drug Industry Drug usage EPO906 (Epothilone B-Novartis)Early Diagnosis Eastern Cooperative Oncology Group Education Educational Materials Educational workshop Effectiveness Elderly Electronic Mail Electronics Employee Strikes Employment Endometrial adenocarcinoma Endometrium Enrollment Ensure Equilibrium Estramustine Estrogens Ethics Ethnic Origin European Event Face Faculty Federal Government Fellowship Female Filgrastim Fire - disasters Florida Fluorouracil Focus Groups Food, Drug and Cosmetic Act Fornet brand of tetrazepam Fostering Foundations Fruit Fulvestrant Funding Funding Opportunities Future Gemtuzumab Ozogamicin Gender Genetic Glioblastoma Goals Government Government regulations Grant Gray unit of radiation dose Grooming Group Meetings Group Structure Growth Guidelines Hand Head and Neck Squamous Cell Carcinoma Health Health Fairs Health Insurance Portability and Accountability Act Health Planning Health Status Health education Hematology Hormone Receptor Hormones Hospitals Human Human Resources Human Subject Research Hydrocortisone/Ketoconazole Imatinib Immunoblastic Lymphadenopathy Immunologics Incidence Individual Industry Information Distribution Informed Consent Injection of therapeutic agent Institutes Institution Insurance Coverage Intellectual Property Interferons Interleukin-11 Internet Interphase Intravenous Investigational Drugs Job Description Joints Journals Knowledge Label Laboratories Laboratory Research Labyrinth Language Lawyers Leadership Legal Length Licensing Life Link Literature Local Area Networks Logistics Loperamide Lymphoblastic Leukemia MYB gene Maintenance Malignant Neoplasms Malignant neoplasm of prostate Manufacturer Name Marimastat Marketing Measures Mediation Medical Medical center Medicare Medicine Methods Minority Mission Modality Modeling Molecular Monitor Monitoring Clinical Trials Motexafin Gadolinium Movement Mucoepidermoid Carcinoma Multiple Myeloma Myeloid Leukemia National Cancer Institute National Cancer Institute of Canada Clinical Trials Group National Surgical Adjuvant Breast and Bowel Project Nature Negative Axillary Lymph Node Neoplasm Metastasis New Agents New England Newly Diagnosed Newsletter Nucleotides Occupational activity of managing finances Octreotide Octreotide Acetate Salt Office for Human Research Protections Operative Surgical Procedures Oprelvekin Outcome Oxidation-Reduction Pamphlets Paper Participant Pathology Pathway interactions Patient Education Patient Participation Patient Representative Patients Peer Review Pemetrexed Pemetrexed Disodium Pennsylvania Peptides Performance Persons Pharmaceutical Preparations Pharmacogenetics Pharmacogenomics Pharmacologic Substance Pharmacology Phase Phase II Clinical Trials Phase III Clinical Trials Philadelphia Philosophy Physicians Pilot Projects Placebos Play Policies Population Positioning Attribute Postmenopause Preparation Press Releases Prevention Primary Care Physician Principal Investigator Printing Procedures Process Product Labeling Production Progesterone Program Evaluation Proteinase-Activated Receptors Proteomics Proto-Oncogene Proteins c-myb Protocols documentation Public Health Public Relations Publications Puerto Rico Purpose Qualifying Quality of life Race Randomized Randomized Clinical Trials Randomized Controlled Clinical Trials Range Rate Recombinants Recommendation Recording of previous events Records Recurrence Refractory Registered nurse Regulation Regulatory Affairs Relapse Relative (related person)Replacement Therapy Reporting Research Research Design Research Ethics Committees Research Infrastructure Research Personnel Research Project Grants Research Proposals Research Support Resistance Resolution Resource Allocation Resources Rights Risk Risk Factors Role Route SDZ-PSC-833 Safety Schedule Science Scientist Screening procedure Secure Selenium Services Signal Transduction Signal Transduction Inhibition Site Slide Sodium Solutions South Africa South America Speed Stable Disease Staff Development Staging Standards of Weights and Measures State Government Statutes and Laws Stem cells Steroids Strategic Planning Structure Suggestion Supplementation Support Groups Support System Surveys System T-Cell Lymphoma Tamoxifen Technology Telephone Television Thalidomide Therapeutic Therapeutic Agents Therapeutics Committee Thinking Time Title To specify Today Touch sensation Toxic effect Training Training and Education Translational Research Transplantation USA Georgia Underrepresented Minority Underserved Population United States United States Dept. of Health and Human Services United States Food and Drug Administration United States National Institutes of Health United States Public Health Service Universities Update Vision Voting Week Western Asia Georgia Wisconsin Woman Work Writing Yeasts ZD1839 (IRESSA)abstracting advocacy organizations anastrozole anti-cancer therapeutic authority base cancer care cancer prevention cancer therapy chemotherapeutic agent chemotherapy clinically relevant college computerized data processing concept coral cost cytotoxic data acquisition data management day design desire docetaxel document outlines dosage drug discovery drug distribution drug market experience falls farnesyltranstransferase follow-up frontier gemcitabine gene therapy glucose transport granulocyte health care delivery hormone therapy human subject hydroxyurea improved innovation interest kidney cell lectures lung small cell carcinoma macrophage male malignant breast neoplasm malignant stomach neoplasm member news novel older patient oncology outcome forecast patient advocacy group patient oriented payment performance site pre-clinical pressure prevent programs prospective prospectuses protein farnesyltransferase protocol development research study response sargramostim sound statistical center stem subcutaneous success symposium symptom management tool trial comparing tumor user-friendly volunteer ward

项目摘要

DESCRIPTION (provided by applicant): This grant is to provide support for the activities of the Eastern Cooperative Oncology Group (ECOG) Chair, Robert L. Comis, M.D.; the senior scientific leadership of the Group; and programs developed by Dr. Comis to enhance the Group's scientific activity and patient accrual. The activities and specific aims supported by this grant are: to provide high quality senior scientific and administrative medical leadership for ECOG programs, and the infrastructure to support that leadership; to expedite the development and conduct of ECOG Studies; and to improve the opportunity for patient participation in ECOG studies.

描述（由申请人提供）：这笔赠款旨在为东部肿瘤合作组 (ECOG) 主席 Robert L. Comis 医学博士的活动提供支持；集团的高级科学领导； Comis 博士为加强集团的科学活动和患者增长而制定的计划。这笔赠款支持的活动和具体目标是：为 ECOG 项目提供高质量的高级科学和行政医疗领导力，以及支持这种领导力的基础设施；加快 ECOG 研究的发展和开展；并增加患者参与 ECOG 研究的机会。